Choose your country to see the products for your location
October is Breast Cancer Awareness Month!
It is estimated 1 in every 8 women will develop breast cancer in their lifetime, of which 5 to 10 percent will be hereditary. Understanding breast cancer risk and early detection are crucial to provide the best care to patients and at-risk individuals. At MRC Holland, we proudly offer a wide range of assays to help with identifying hereditary breast cancer and at-risk individuals.
Below you can find a list of the CE-marked SALSA® MLPA® probemixes that we offer:
If you would like more information, please contact us at firstname.lastname@example.org.